Aurobindo Pharma delays 26% stake acquisition in Swarnaakshu Solar
Aurobindo Pharma (BSE:AUROPHARMA) has announced a delay in its previously communicated plan to acquire up to a 26% stake in Swarnaakshu Solar Power Private Limited. The company informed exchanges that pending receipt of state government approval for setting up a captive solar power plant, the acquisition, initially slated for completion by June 30, 2025, will now be completed on or before September 30, 2025. This is subject to the receipt of approval from the concerned state government. The company had previously informed the exchange of its intent to enter into a captive solar power purchase agreement and stake acquisition in letters dated February 6, 2025, and March 28, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Aurobindo Pharma publishes news
Free account required • Unsubscribe anytime